Search Results - Allan Dunlop
- Showing 1 - 1 results of 1
-
1
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients by Neil Chanchlani, Simeng Lin, Desmond Chee, Benjamin Hamilton, Rachel Nice, Zehra Arkir, Claire Bewshea, Bessie Cipriano, L Derikx, Allan Dunlop, Louise Greathead, Rachel L Griffiths, Hajir Ibraheim, Peter Kelleher, Klaartje Kok, Charlie W. Lees, Jonathan Macdonald, Shaji Sebastian, Philip J Smith, Timothy J. McDonald, Peter M. Irving, Nick Powell, Nicholas A. Kennedy, James Goodhand, Tariq Ahmad
Published 2021Artigo
Search Tools:
Related Subjects
2019-20 coronavirus outbreak
Adalimumab
Antibody
Coronavirus disease 2019 (COVID-19)
Disease
Drug
Drug holiday
Human immunodeficiency virus (HIV)
Immunology
Infectious disease (medical specialty)
Infliximab
Internal medicine
Medicine
Outbreak
Pharmacology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Therapeutic drug monitoring
Tumor necrosis factor alpha
Virology